APP13007's active ingredient is the superpotent corticosteroid, clobetasol propionate, and is derived from Formosa Pharma's proprietary APNT ® nanoparticle formulation platform. The novel ...

APP13007's active ingredient is the superpotent corticosteroid, clobetasol propionate, and is derived from Formosa Pharma's proprietary APNT ® nanoparticle formulation platform. The novel formulation, ...

TAIPEI, May 28, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Adalvo Limited ...

Director Lee Sang-il‘s Kabuki drama “Kokuho,” screening at Cannes Directors’ Fortnight, represents the culmination of a 15-year creative journey, bringing to life a sweeping tale of ...

Tommy Lee and his wife Brittany Furlan have separated over his drinking. Sources close to Lee, 62, and Furlan, 38, told TMZ Thursday that the heavy metal staple and comic/influencer have not ...

Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Apotex for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic ...

Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) was approved by the U.S. Food and Drug Administration (FDA) in 2024. APP13007's active ingredient is the superpotent corticosteroid, ...

Clobetasol propionate ophthalmic suspension, 0.05% (APP13007), approved by the U.S. Food and Drug Administration (FDA) in March, 2024, was launched in the United States in September. The ...